Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Oncology Research and Treatment|June 15, 2025
Managing Antithrombotic Treatment in Patients with Immune ThrombocytopeniaRosa Sonja Alesci, Oliver Meyer, Hanno Riess, et al.
Hamostaseologie|April 30, 2024
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k GuidelineRobert Klamroth, Hanno Riess, Jan Beyer-Westendorf, et al.
World Journal of Gastrointestinal Oncology|March 19, 2016
Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - ReviewHanno Riess, Piet Habbel, Anja Jühling, et al.
BMC Cancer|April 26, 2006
Intraluminal instillation of urokinase and autologous plasma: a method to unblock occluded central venous portsGeorg Seifert, Hanno Riess, Karl Seeger, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 28, 2006
[Recent progress in the treatment of colorectal cancer]Peter C Thuss-Patience, Peter Reichardt, Hanno Riess, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactionsHanno Riess, Paolo Prandoni, Sebastian Harder, et al.
Hamostaseologie|November 22, 2023
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k GuidelineHanno Riess, Jan Beyer-Westendorf, Uwe Pelzer, et al.
Hamostaseologie|December 8, 2021
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)-German Practice of Anticoagulation Therapy of Cancer Patients with ThrombosisHanno Riess, Albrecht Kretzschmar, Andreas Heinken, et al.
Oral Oncology|December 25, 2003
Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumourJan-Dirk Raguse, Hans Joachim Gath, Jürgen Bier, et al.
World Journal of Gastrointestinal Oncology|March 19, 2016
Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survivalMarianne Sinn, Marcus Bahra, Timm Denecke, et al.
Pageof 15